Researchers have found a way to make cancer-killing immune cells more powerful and precise. By adding specific signaling components, they boosted the cells’ readiness to attack tumors. Surprisingly, ...

HaystackMRD, made by Haystack Oncology within Quest Diagnostics, looks for signs of cancer that conventional methods may miss ...

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...

Breast02, led by a senior medical oncologist and researcher from the National Cancer Centre Singapore, has demonstrated a ...

These advances, still under investigation, hold the promise of revolutionizing healthcare for future colorectal cancer ...

A team developing light-sensitive cancer drugs has won a US$2-million Quantum for Bio (Q4Bio) prize for demonstrating a ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.